消息

The guidance triggered a sharp market reaction. Shares fell 18 % in Copenhagen and up to 20 % on 4 Feb 2026 following the 2026 outlook, wiping approximately $32 bn–$47 bn of market value. The decline was driven by expectations of a 13 % drop in 2026 sales and profits, the first negative growth outlook in years, and intensified competition from gene...

全文

During its Q4 earnings call on 4 Feb 2026, Novo highlighted a forecasted decline of 5 %–13 % in sales and operating profit at constant exchange rates for 2026. The outlook cites lower realized prices, U.S. pricing effects under President Trump’s MFN policy and the IRA, mix and cash‑pay shifts, and the loss of semaglutide exclusivity in Brazil, Cana...

全文

Novo Nordisk AS reported 10 % sales growth and 6 % operating‑profit growth for 2025 at constant exchange rates. Obesity‑care revenue climbed from DKK 6 bn in 2019 to DKK 82 bn in 2025, a 31 % annual growth rate, while GLP‑1 sales expanded over 30 % in 2025. Wegovy generated DKK 28 bn in international sales, up 134 % versus the prior year, and Ozemp...

全文

OXB announced a new Commercial Supply Agreement with Bristol Myers Squibb (BMS) to manufacture and supply lentiviral vectors for BMS’ CAR‑T programmes. The partnership, originally established in 2020, will shift to commercial production in 2026, pending regulatory approval. The multi‑year deal is projected to generate significant revenue, reinforci...

全文

Cars Commerce Inc. (NYSE: CARS) announced a partnership with Del Grande Dealer Group and Salesforce to launch DealerCloud LLC, a new automotive CRM built on Salesforce’s Agentforce Automotive platform. The solution targets long‑standing inefficiencies in auto‑retail CRMs by offering a modern, intuitive system that merges data across OEMs, retailers...

全文

Wall Street analysts anticipate a year‑over‑year earnings decline for Porch Group, Inc. (PRCH) in the quarter ended December 2025. The consensus EPS estimate is –$0.07 per share, a 146.7 % drop from the same period last year. Revenues are projected at $108.64 million, up 8.3 % from the previous quarter. The Zacks Earnings ESP model signals a negati...

全文

The appointment comes as Cadiz positions itself to meet rising demand for clean water and energy resources. The company controls 45,000 acres of land in California, 2.5 million acre‑feet of water supply, and 220 miles of pipeline assets. With O’Hara’s guidance, Cadiz aims to address climate‑change‑related challenges to water access and accelerate s...

全文

Cadiz, Inc. (NASDAQ: CDZI) has added Dave O’Hara to its Board of Directors. O’Hara, a veteran finance executive, spent more than two decades at Microsoft, where he served as Executive Vice President and Chief Financial Officer of the Commercial Business Group. His experience in corporate finance, commercial strategy, and large‑scale capital‑intensi...

全文

Embla Medical reported Q4 2025 sales of USD 257 million, up 14% in USD terms and 10% in local currency, with organic growth of 7% versus 5% in Q4 2024. FY 2025 organic sales growth was 6%. EBITDA margin for the quarter fell to 19% from 21% due to FX, tariffs, and initiatives aimed at long‑term profitability in Patient Care. Net profit rose 33% to U...

全文

NVZMY holds a Zacks Rank of #2 (Buy) versus HWKN’s #3 (Hold), reflecting a sharper earnings‑outlook improvement for the former. Forward‑looking valuation multiples reinforce NVZMY’s relative appeal: its forward P/E sits at 24.53 compared with HWKN’s 31.23, and its PEG ratio is 1.11 against HWKN’s 1.95. The price‑to‑book metric also favours NVZMY, w...

全文